The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Genentech/Roche; Lilly; Merck Serono; MSD; Novartis; Roche; Sanofi; Symphogen; Taiho Pharmaceutical
Population pharmacokinetics (popPK) of Sym004 to evaluate the effect of intrinsic and extrinsic factors on exposure in metastatic colorectal cancer (mCRC).
 
Lene Alifrangis
Employment - Symphogen
Stock and Other Ownership Interests - Novo Nordisk; Symphogen
 
Rik Schoemacker
Honoraria - Merck KGaA; Pfizer; Symphogen; UCB
Consulting or Advisory Role - Merck KGaA; Pfizer; Symphogen; UCB
 
Niels Jorgen Ostergaard Skartved
Employment - Symphogen
Stock and Other Ownership Interests - Symphogen
 
Rikke Hald
Employment - Symphogen
Stock and Other Ownership Interests - Symphogen
 
Maria Düring
Stock and Other Ownership Interests - Novo Nordisk
Consulting or Advisory Role - Leo Pharma; Symphogen
 
Clara Montagut
No Relationships to Disclose
 
Guillem Argiles
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech/Roche; Roche; SERVIER
Travel, Accommodations, Expenses - Amgen; Bayer; Roche; SERVIER
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch; Navire
Consulting or Advisory Role - Amal Therapeutics; Biocartis; EMD Serono; Genentech; Holy Stone Healthcare; Holy Stone Healthcare; Karyopharm Therapeutics; Merck; Navire; Roche; Symphogen
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)
 
Ivan David Horak
Employment - Symphogen
Stock and Other Ownership Interests - Symphogen
 
Michael Kragh
Employment - Symphogen
Stock and Other Ownership Interests - Symphogen
 
Janet R Wade
Consulting or Advisory Role - Merck KGaA (Inst); PCI Biotech (Inst); Symphogen (Inst)